Clinical trial
Effects of CHD Prevention on Lipoprotein Subclasses
NCT00005426 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00005426 |
|---|---|
| Title | Effects of CHD Prevention on Lipoprotein Subclasses |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Coronary Disease, Heart Diseases |
| Start date | May 1, 1993 |
| Completion | Dec 1, 1994 |
| First posted | May 26, 2000 |
| Last update posted | Feb 29, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: